Union Ministry of Health and Family Welfare Amends Drugs Rules, 1945; Exemption for Sale of Cough Syrups in Small Villages Withdrawn

The Ministry of Health and Family Welfare has notified the Drugs (Fifth Amendment) Rules, 2026, which removes the word "Syrup" from Serial No. 13, Entry 7 of...

What Happened

The Ministry of Health and Family Welfare has notified the Drugs (Fifth Amendment) Rules, 2026, which removes the word "Syrup" from Serial No. 13, Entry 7 of Schedule K of the Drugs and Cosmetics Rules, 1945.
This change means that all cough syrups — and syrup-based medicines more broadly — can no longer be sold over the counter in any part of India, including small villages and remote areas where the Schedule K exemption previously applied.
A valid prescription from a registered medical practitioner is now mandatory for the purchase of any syrup formulation that was previously exempt under Schedule K.
The amendment came into force with immediate effect from the date of its publication in the Official Gazette (effective 9 June 2026).
The policy change is a regulatory response to documented misuse of codeine-containing cough syrups and to cases of harm linked to unsupervised consumption of syrup formulations, including the child deaths abroad linked to contaminated Indian-manufactured syrups in 2025.

Static Topic Bridges

Drugs and Cosmetics Act 1940 and Rules 1945: Regulatory Architecture

The Drugs and Cosmetics Act, 1940 (DCA) is the primary legislation governing the manufacture, sale, distribution, and import of drugs and cosmetics in India. It was enacted to ensure that drugs available in the market meet standards of quality, safety, and efficacy. The Drugs and Cosmetics Rules, 1945 are the subordinate legislation made under the DCA and contain the operative detail — including Schedules that classify drugs by their dispensing requirements, manufacturing standards, and storage conditions. The Central Government (Ministry of Health and Family Welfare) has the power to amend Schedules to the Rules through gazette notification.

Drugs and Cosmetics Act 1940: primary law; regulates manufacture, sale, import of drugs/cosmetics
Drugs and Cosmetics Rules 1945: subordinate rules; contain operative schedules
Key drug schedules: Schedule H (prescription-only drugs), Schedule H1 (enhanced prescription requirements for habit-forming drugs), Schedule X (controlled psychotropic/narcotic substances), Schedule K (exemptions from standard licensing requirements in specific contexts)
Central Drugs Standard Control Organisation (CDSCO): national regulatory authority under DGHS, Ministry of Health
State Drug Controllers: regulate manufacturing licenses; DCA enforcement is concurrent (Centre + States)

Connection to this news: The amendment modifies Schedule K — a specific exemptions schedule — within the Drugs and Cosmetics Rules, 1945, tightening a regulatory gap that had existed since the Rules were first framed.

Schedule K: What the Exemption Was and Why It Mattered

Schedule K of the Drugs and Cosmetics Rules, 1945 lists categories of drugs and contexts where certain provisions of the Act — particularly those requiring licensed pharmacists and retail drug licences — do not apply. Serial No. 13, Entry 7 previously listed "Syrups" as a category exempt from standard retail licensing and prescription requirements in specific settings (small villages lacking pharmacies). This exemption was historically justified by the need to ensure rural access to basic medicines. However, the same exemption created a loophole: cough syrups containing controlled or potentially habit-forming substances (such as codeine) could be sold without a prescription in these areas.

Schedule K exemptions: allow sale of certain drugs without the full DCA licensing/prescription framework in specified settings
Previous exemption (now removed): syrups could be sold in village settings without prescription
The amendment omits "Syrup" from the exemption — meaning all syrups now require prescription regardless of geography
Impact: universal coverage of prescription requirement — rural health providers will need to adjust procurement and dispensing protocols
Pharmacy Act 1948: separately regulates pharmacies and pharmacists; Schedule K amendments do not override Pharmacy Act licensing

Connection to this news: By removing the Schedule K exemption for syrups, the government has closed a regulatory gap that allowed potentially dangerous formulations to reach consumers without medical oversight, particularly in underserved rural areas.

Codeine and the Drug Abuse Concern

Codeine is an opiate alkaloid used medically as an analgesic and cough suppressant. In India, codeine-containing cough syrups are classified as Schedule H and Schedule H1 drugs under the Drugs and Cosmetics Rules — meaning they already require prescriptions in standard retail settings. However, the Schedule K exemption had created a parallel pathway for certain rural settings. Codeine is also regulated under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985 for higher-concentration formulations. Misuse of codeine-based cough syrups (often consumed in combination with alcohol or other substances) has been documented across multiple Indian states, leading to addiction, psychosis, and deaths.

Codeine: Schedule H and H1 drug in standard retail; additionally regulated under NDPS Act for high-concentration forms
Each 5 ml dose of codeine cough syrup typically contains ~10 mg codeine phosphate
NDPS Act 1985: governs narcotic drugs and psychotropic substances; offences include possession, sale, trafficking without authorisation
Schedule H: prescription mandatory; labelling must carry "Rx" symbol; schedule must be mentioned on packaging
Schedule H1: introduced in 2013 for habit-forming drugs; pharmacy must maintain separate register; additional record-keeping requirements
International context: WHO and WHO FCTC have flagged codeine misuse in low- and middle-income countries

Connection to this news: The prescription mandate for syrups is partly aimed at curbing the misuse of codeine-based formulations that were slipping through the Schedule K exemption pathway.

Pharmacy Act 1948 and the Regulatory Ecosystem

The Pharmacy Act, 1948 establishes the Pharmacy Council of India (PCI) and regulates the practice of pharmacy — including who can dispense drugs, conditions for pharmacy licensing, and educational requirements for pharmacists. It operates alongside the Drugs and Cosmetics Act: the DCA controls what drugs can be sold and under what conditions; the Pharmacy Act controls who can sell them. The amendment to Schedule K strengthens the DCA side of this regulatory ecosystem. However, for the amendment to be effective on the ground, enforcement through the Pharmacy Act framework — inspections, licensed pharmacies, qualified pharmacists — must also function in rural areas.

Pharmacy Council of India (PCI): statutory body under Pharmacy Act 1948; regulates pharmacy education and practice
D.Pharm (2 years) and B.Pharm (4 years): minimum qualification for retail pharmacy operations
Pharmacy Act 1948 + DCA 1940 together form the backbone of India's drug retail regulatory framework
Implementation challenge: ~70% of India's pharmacies are in urban/semi-urban areas; rural health sub-centres often operate without licensed pharmacists

Connection to this news: The amendment's intended public health benefit depends on parallel strengthening of pharmacy infrastructure in rural areas — otherwise the prescription requirement may simply reduce access without improving safety.

Key Facts & Data

Amendment: Drugs (Fifth Amendment) Rules, 2026; notified June 9, 2026; immediate effect
Change: "Syrup" removed from Schedule K, Serial No. 13, Entry 7 — ends OTC sale of syrups in all geographies
Drugs and Cosmetics Act 1940: primary legislation; Drugs and Cosmetics Rules 1945: subordinate rules containing schedules
Schedule H: prescription-required drugs; Schedule H1: enhanced restrictions (habit-forming drugs, introduced 2013)
Codeine: Schedule H/H1 drug; also regulated under NDPS Act 1985 for high-concentration forms
Pharmacy Council of India: statutory body under Pharmacy Act 1948
CDSCO: national drug regulatory authority under Ministry of Health and Family Welfare
Background context: Indian-manufactured cough syrup linked to child deaths abroad (2025); WHO advisory on Indian cough syrup manufacturers issued 2022–23